Latest Breaking News On - Six minute walk test - Page 6 : comparemela.com

Myotonic dystrophy type 1 (DM1) is an incurable multisystem disease caused by a CTG-repeat expansion in the DM1 protein kinase (DMPK) gene. The OPTIMISTIC clinical trial demonstrated positive and heterogenous effects of cognitive behavioral therapy (CBT) on the capacity for activity and social participations in DM1 patients. Through a process of reverse engineering, this study aims to identify druggable molecular biomarkers associated with the clinical improvement in the OPTIMISTIC cohort. Based on full blood samples collected during OPTIMISTIC, we performed paired mRNA sequencing for 27 patients before and after the CBT intervention. Linear mixed effect models were used to identify biomarkers associated with the disease-causing CTG expansion and the mean clinical improvement across all clinical outcome measures. We identified 608 genes for which their expression was significantly associated with the CTG-repeat expansion, as well as 1176 genes significantly associated with the average

Picard genotypeconcordanceMyotonic dystrophy health indexCentre for rare neuromuscular diseasesLibrary prep kit illuminaIndividualized neuromuscular qualityLife questionnaireAdult social behavioural questionnaireIllness management questionnaireSix minute walk testDaytime sleepiness scaleChecklist individual strengthJacobsen fatigue catastrophizingNew castleNeuromuscular diseasesTempus spinThermo fisher scientific